And Phase I looks to be planning to start this year!
Do you know a bit about how they plan to sell it post-Phase I? I recall that Pfizer was a likely target? Makes sense, Pfizer is being touted by many biotech analysts and commentators as likely to be acquiring some companies in the near future, given their covid vaccine revenue and small/mid cap biotech market caps beaten down in general across the board.
Ann: Investor Roadshow Presentation, page-7
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.031(31.3%) |
Mkt cap ! $22.77M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 13.5¢ | 11.0¢ | $449.8K | 3.581M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 100000 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 226437 | 5 |
View Market Depth
| Last trade - 11.33am 16/10/2024 (20 minute delay) ? |
| NYR (ASX) Chart |